why choose us

First received: December 26, 2022

Clinical Trial: Autotaxin: a Potential Biomarker for Breast Cancer.

Study Status: Completed

Recruit Status: Completed

Condition: Breast Cancer

Study Type: Interventional


Official Title: Is Autotaxin a Promising Biomarker for Breast Cancer

Brief Summary: The goal of this clinical trial is to test the efficiency of Autotaxin (ATX) as a biomarker for breast cancer patients.The main questions it aims to answer are;is ATX a reliable tumor marker for breast cancer patients in diagnosiscan ATX differentiate cancer patients from non-cancer ones

Read more